GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
As we mentioned on our list of the top 30 venture capital firms of 2013, VC is part of what makes new biotechs and biopharmas blossom. Although our list is over three pages long and there seem to be an abundance of VC firms funding biopharma startups, have you ever had any problems getting capital for one of your ventures?